In:
Cancer, Wiley, Vol. 106, No. 10 ( 2006-05-15), p. 2241-2246
Abstract:
The combination of irinotecan and oxaliplatin appears to be safe and active when used to treat patients with metastatic colorectal cancer. Treatment results with this regimen were found to be similar to those reported for other combined frontline chemotherapy regimens for colorectal cancer. When this particular regimen was used, neutropenia was the predominant toxicity.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v106:10
Language:
English
Publisher:
Wiley
Publication Date:
2006
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Permalink